Mayne Pharma Group (AU:MYX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Mayne Pharma Group Limited announced the cessation of 13,212 of its performance rights securities due to the non-fulfillment of conditional rights. This announcement, dated Friday, September 13, 2024, specifies that these rights lapsed because the conditions tied to them were either not satisfied or became incapable of being satisfied by September 11, 2024.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
